3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-6,7-DIHYDRO-5H-PYRAZOLO[5,1-B][1,3]OXAZINE, 95.0%, 100mg

2-(Quinuclidin-3-yl)acetic acid hydrochloride, 98%, 100mg

(R)-2-Fluoro-5-methyl-N-(4-(4-(morpholin-2-ylmethoxy)-1H-pyrazolo[3,4-d]pyrimidin-6-yl)phenyl)benzenesulfonamide hydrochloride, 5mg

tert-Butyl 3-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole-1-carboxylate, 97%, 250mg

5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-ol, 95.0%, 5g

(2E)-1-(4-ethoxyphenyl)-3-(4-methoxyphenyl)prop-2-en-1-one, 95.0%, 2g

1-(2,2-Diethoxyethyl)pyrrolidine, 95+%, 100mg

(2E)-1-(2-methylphenyl)-3-phenylprop-2-en-1-one, 95.0%, 10g

2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid, 95.0%, 10g

Óxido de manganeso(IV) en polvo 99,9% 50 g

1-Methyl-1H-pyrazole-4-sulfonamide, 1g

1-(2-Nitrophenyl)pyrrole, 97%, 1g

2-amino-4-tert-butyl-3-furonitrile, 95.0%, 1g